DermTech Inc at ICR Virtual Conference Transcript
Welcome, and thank you for joining us. I'm Caroline Corner, Managing Director at Westwicke ICR in medical technology practice. We've all had or know someone who's had a mole removed during a skin cancer scare, and many of us have the scars to prove it. The client DermTech is using their smart sticker technology, which is pressed onto a suspicious mole to remove skin's genetic material to test for melanoma.
Today, I'm here with DermTech's Chief Financial Officer, Kevin Sun; who earlier this month completed a $125 million equity financing to fuel their launch and pipeline plans. Kevin, welcome, and I'll turn it over to you.
Great. Thank you, Caroline, and thank you, everyone, for joining us today to learn a little bit about our company.
First, our standard disclaimer language. We usually like to start talking about our company with our leadership team. We've got a tremendous leadership team here. John Dobak, our CEO, has been with us the longest. He is an entrepreneur at heart
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |